Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Vasculitis, Emergency Medicine


Basics


Description


  • Injury to the walls of blood vessels from inflammation:
    • Ischemia and necrosis
    • Aneurysms and hemorrhage
    • Immunopathologic mechanisms:
      • Deposition of circulating antigen " “antibody complex and complement fixation
      • Cell-mediated hypersensitivity
      • Granulomatous tissue reaction from persistent inflammation and formation of epithelioid giant cells
  • The vasculitides represent a wide group of disorders:
    • Multisystem disease with constitutional symptoms and inflammatory lab indices
    • Secondary to another disorder or trigger, or primary if vasculitis is the principal feature and the cause is unknown
    • Multiple factors determine presentation:
      • The size of the affected blood vessels
      • The specific distribution, severity, and duration of the inflammation
      • Degree of permeability or occlusion of the affected vessels
  • 1 out of 2,000 adults has some form of vasculitis

Etiology


  • Classification is evolving and is increasingly based on presence or absence of antineutrophil cytoplasmic antibodies (ANCA).
  • Traditional classification is based on vessel size.
  • Large vessel vasculitides:
    • Temporal (giant cell) arteritis:
      • Granulomatous arteritis of the aorta and its major branches often involving the temporal artery
      • Patients >50 yr
    • Takayasu arteritis:
      • Granulomatous inflammation of the aorta and its major branches
      • Usually occurs in patients <50 yr
  • Medium vessel vasculitides:
    • Polyarteritis nodosa (PAN):
      • Small- and medium-sized arteritis
      • Common distribution includes vessels supplying the muscles, joints, intestines, nerves, kidneys, and skin
      • Most common in middle age
    • Kawasaki disease (mucocutaneous lymph node syndrome):
      • Coronary arteries are often involved and involves large-, medium-, and small-sized arteries
      • Usually occurs in children
    • Isolated CNS vasculitis
  • Small vessel vasculitides:
    • Granulomatosis with polyangiitis (Wegener granulomatosis):
      • Necrotizing vasculitis affecting small- to medium-sized vessels
      • Granulomatous inflammation of the upper and lower respiratory tract and glomerulonephritis
    • Microscopic polyangiitis:
      • Necrotizing affecting small vessels
      • Glomerulonephritis is very common.
      • Pulmonary capillaritis often occurs.
    • Churg " “Strauss syndrome (allergic granulomatosis):
      • Small- and medium-sized arteries
      • Mainly lungs, GI, and nerves
      • Can also involve heart, skin, and kidney
    • Henoch " “Sch ƒ ¶nlein purpura:
      • Most patients <20 yr
    • Buerger disease (thromboangiitis obliterans):
    • Hypersensitivity vasculitis:
      • Recurring inflammation and thrombosis of small and medium arteries and veins of the hands and feet
      • Typically between 20 and 40 yr and male
    • Secondary vasculitides:
      • Bacterial infections:
        • Streptococcal, tuberculous, staphylococcal, Lyme disease, leprosy
      • Viral infections:
        • Hepatitis B or C, CMV, HSV, HIV
      • Rickettsial infections
      • Drug related
      • Connective tissue disease:
        • Systemic lupus erythematosus
        • Rheumatoid arthritis
        • Beh ƒ §et disease
      • Malignancy:
        • Hairy cell leukemia
        • Lymphoma
      • Mixed cryoglobulinemia
      • Goodpasture syndrome
      • Serum sickness

Diagnosis


Signs and Symptoms


  • Systemic complaints are common early in the presentation of vasculitis, before vascular-related complications occur:
    • Fever, fatigue, weight loss, diffuse aches and pains
  • Signs of arterial insufficiency:
    • Ischemic pain:
      • Angina, abdominal angina, claudication, jaw claudication
    • Neurologic ischemia:
      • Headache, TIA, stroke, visual and sensorineural hearing loss, hallucinations, neuropathy, vision loss
    • Renal ischemia:
      • Severe or resistant HTN
    • Dermatologic ischemia:
      • Classic skin findings include palpable purpura.
      • Nodular lesions, ulcers, livedo reticularis, and digital ischemia may also be seen
    • Oligoarthritis
    • Ocular ischemia:
      • Diplopia, retinal hemorrhages, scleritis, and episcleritis
    • Respiratory tract:
      • Sinusitis, epistaxis, nasal and oral ulcerations, strawberry tongue
    • GI ischemia:
      • Hematochezia, melena, hematemesis, peritonitis, hepatitis
    • Cardiac:
      • Coronary artery aneurysms, myocarditis, pericarditis, valvular disease, CHF

History
  • Suspect vasculitis with general systems and signs of arterial insufficiency:
    • Claudication, angina, abdominal angina, or TIA, in a young patient
    • Prolonged systemic illness with multiorgan dysfunction
    • History of glomerulonephritis, peripheral neuropathy, or autoimmune disease
  • Diagnostic clues to the etiology:
    • Age, gender, ethnicity, travel history
    • Specific complaints that suggest the size of the involved vessel and organs
    • Recent infections
    • Connective tissue disorders
    • Medications that may cause vasculitis:
      • Levsamisole (as a cocaine adulterant), phenytoin, carbamazepine, isoniazid, methimazole, minocycline, penicillamine, propylthiouracil, sulfasalazine

Physical Exam
Classify vasculitis: ‚  
  • Large arteries:
    • Diminished pulses and bruits over several large arteries
    • BP discrepancy >10 mm Hg between left and right limbs
    • Pulse discrepancy >30 mm Hg between the left and right limbs
    • Cool extremities due to claudication and ulceration
  • Medium and small arteries:
    • Palpable purpura (nodules, ulcers, livedo papules)
    • Skin ulcers
    • Digital ischemia

Essential Workup


  • History and physical exam
  • CBC, ESR, CRP, urinalysis, BUN, creatinine

Diagnosis Tests & Interpretation


Lab
  • CBC:
    • Leukocytosis
    • Eosinophilia
    • Anemia
  • Creatinine
  • LFT
  • CRP
  • ESR
  • ANA
  • ANCA
  • Complement
  • CPK
  • Urinalysis:
    • Proteinuria and hematuria

Imaging
  • CXR:
    • PAN usually has a nonspecific patchy alveolar infiltration.
  • CT scan:
    • Sinus CT for suspected granulomatosis with polyangiitis (Wegener)
  • CTA:
    • Coronary artery aneurysms in Kawasaki
  • Echocardiography:
    • Coronary artery aneurysms in Kawasaki
  • MRI and MRA:
    • Positron emission tomography (PET) scan for suspected Takayasu and Kawasaki
  • ECG:
    • Indications:
      • Suspected Takayasu and Kawasaki
  • US:
    • Temporal artery US for suspected giant cell arteritis
    • Use pretest probability in interpretation of results
  • Arteriography

Diagnostic Procedures/Surgery
  • EKG:
    • Pericarditis, conduction disturbances
  • Endoscopy, sigmoidoscopy, and colonoscopy for GI tract involvement
  • Tissue biopsy

Differential Diagnosis


  • Endocarditis
  • Adverse drug reaction
  • Viral infections (e.g., enterovirus)
  • Scarlet fever " ¨
  • Staphylococcal scalded skin syndrome " ¨
  • Toxic shock syndrome " ¨
  • Stevens " “Johnson syndrome
  • Rocky Mountain spotted fever " ¨
  • Leptospirosis
  • Antiphospholipid antibody syndrome
  • Disseminated intravascular coagulation
  • Cholesterol emboli
  • Calciphylaxis

Treatment


Initial Stabilization/Therapy


Stabilization of cerebrovascular complications ‚  

Ed Treatment/Procedures


  • Treatment for vasculitis is determined by the underlying cause or the specific disease and is best initiated by rheumatology.
  • Kawasaki: Aspirin, IVIG
  • Giant cell arteritis: Corticosteroids
  • PAN: Steroids, cyclophosphamide
  • Takayasu arteritis: Corticosteroids, methotrexate, azathioprine, cyclophosphamide
  • Wegner granulomatosis: Corticosteroids:
    • Cyclophosphamide, azathioprine may be substituted
    • Plasma exchange may be helpful in severe disease.

Medication


  • Azathioprine: 2 mg/kg/d PO
  • Cyclophosphamide:
    • IV: 0.5 " “1 mg/m2 body surface area
    • PO: 2 mg/kg/d (up to 4 mg/kg) (peds: dose as per consultant)
  • IVIG: 1 " “2 g/kg IV
  • Methylprednisolone: 0.25 " “1 mg/d IV
  • Methotrexate: 7.5 " “15 mg/wk PO
  • Prednisolone: 1 mg/kg/d PO
  • Prednisone: 40 " “60 mg/d (peds: 1 " “2 mg/kg/d) PO

Follow-Up


Disposition


Admission Criteria
  • Patients with evidence of severe disease and end-organ dysfunction should be admitted.
  • Consult for procedures to revascularize ischemic organs.

Discharge Criteria
Less-symptomatic patients without evidence of end-organ involvement ‚  
Issues for Referral
  • Any patient suspected of vasculitis and being managed as an outpatient should be referred as soon as possible to a rheumatologist for the definitive diagnosis and treatment.
  • Consult appropriate specialties based on the severity of the end-organ damage.

Followup Recommendations


Stress the need for close follow-up with general symptoms to confirm the diagnosis and initiate therapy that will be life-saving on a long-term basis. ‚  

Pearls and Pitfalls


  • Drug therapy may be toxic; do not prescribe without specialist consultation.
  • Patients may be immunosuppressed and at risk for opportunistic pathogens.
  • Do not miss subacute bacterial endocarditis as a mimic of vasculitis.
  • Temporal (giant cell) arteritis does not occur before age 50 yr.
  • Nodular lesions are the skin changes most likely to yield a diagnosis of vasculitis.

Additional Reading


  • Langford ‚  CA. Vasculitis. J Allerg Clin Immunol.  2010;125(2 suppl 2):S216 " “S225.
  • Lapraik ‚  C, Watts ‚  R, Bacon ‚  P, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford).  2007;46(10):1615 " “1616.
  • Mukhtyar ‚  C, Guillevin ‚  L, Cid ‚  MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis.  2009;68(3):310 " “317.
  • Newburger ‚  JW, Takahashi ‚  M, Gerber ‚  MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics.  2004;114(6):1708 " “1733.
  • Semple ‚  D, Keogh ‚  J, Forni ‚  L, et al. Clinical review: Vasculitis on the intensive care unit-part 1: Diagnosis. Crit Care.  2005;9(1):92 " “97.
  • Semple ‚  D, Keogh ‚  J, Forni ‚  L, et al. Clinical review: Vasculitis on the intensive care unit-part 2: Treatment and prognosis. Crit Care.  2005;9(2):193 " “197.

See Also (Topic, Algorithm, Electronic Media Element)


  • Erythema Nodosum
  • Henoch " “Sch ƒ ¶nlein Purpura
  • Hepatitis
  • Reiter Syndrome
  • Systemic Lupus Erythematosus

Codes


ICD9


  • 446.0 Polyarteritis nodosa
  • 446.5 Giant cell arteritis
  • 447.6 Arteritis, unspecified
  • 443.1 Thromboangiitis obliterans [Buergers disease]

ICD10


  • I77.6 Arteritis, unspecified
  • M30.0 Polyarteritis nodosa
  • M31.6 Other giant cell arteritis
  • I73.1 Thromboangiitis obliterans [Buergers disease]
  • M31.4 Aortic arch syndrome [Takayasu]

SNOMED


  • 31996006 Vasculitis (disorder)
  • 400130008 Temporal arteritis (disorder)
  • 155441006 Polyarteritis nodosa (disorder)
  • 52403007 Thromboangiitis obliterans (disorder)
  • 11791001 Necrotizing vasculitis (disorder)
  • 359789008 Takayasus disease (disorder)
  • 70933002 Aortitis (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer